A Rapid Fatal Evolution of Coronavirus Disease-19 in a Patient With Advanced Lung Cancer With a Long-Time Response to Nivolumab

J Thorac Oncol. 2020 Jun;15(6):e83-e85. doi: 10.1016/j.jtho.2020.03.021. Epub 2020 Mar 31.

Authors

Lucia Bonomi¹, Laura Ghilardi², Ermenegildo Arnoldi², Carlo Alberto Tondini², Anna Cecilia Bettini²

Affiliations

¹ Oncology Unit, Azienda Socia Sanitaria Territoriale Ospedale Papa Giovanni XXIII, Bergamo, Lombardia, Italy. Electronic address: lbonomi@asst-pg23.it.
² Oncology Unit, Azienda Socia Sanitaria Territoriale Ospedale Papa Giovanni XXIII, Bergamo, Lombardia, Italy.

No abstract available

Publication types

Letter
Comment

MeSH terms

Betacoronavirus
COVID-19
China
Coronavirus Infections
Coronavirus*
Humans
Lung Neoplasms*
Nivolumab
Pandemics
Pneumonia, Viral
SARS-CoV-2
Severe acute respiratory syndrome-related coronavirus*

Substances

Nivolumab